英夫利昔单抗成功治疗黏膜类天疱疮。 - Suppr

Suppr

超能文献

Successful treatment of mucous membrane pemphigoid with infliximab.

作者信息

Heffernan Michael P, Bentley Danette D

机构信息

Divisions of Dermatology, Wright State University School of Medicine, Dayton, Ohio 45408-1445, USA.

出版信息

Arch Dermatol. 2006 Oct;142(10):1268-70. doi: 10.1001/archderm.142.10.1268.

DOI:10.1001/archderm.142.10.1268

PMID:17043180

Abstract

摘要

相似文献

Successful treatment of mucous membrane pemphigoid with infliximab.

Arch Dermatol. 2006 Oct;142(10):1268-70. doi: 10.1001/archderm.142.10.1268.

Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.

Arch Dermatol. 2006 Nov;142(11):1457-61. doi: 10.1001/archderm.142.11.1457.

Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.

Eye (Lond). 2007 Nov;21(11):1434-5. doi: 10.1038/sj.eye.6702948. Epub 2007 Aug 10.

[Mucous membrane pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].

Ann Dermatol Venereol. 2011 Mar;138(3):259-63. doi: 10.1016/j.annder.2011.01.014. Epub 2011 Feb 22.

Benign mucous membrane pemphigoid with advanced periodontal involvement: diagnosis and therapy.

J Periodontol. 1995 Aug;66(8):737-41. doi: 10.1902/jop.1995.66.8.737.

Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.

J Drugs Dermatol. 2007 Jul;6(7):731-2.

[Cicatricial pemphigoid, mucous membrane pemphigoid].

Presse Med. 2010 Oct;39(10):1049-57. doi: 10.1016/j.lpm.2010.07.001. Epub 2010 Sep 17.

Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.

J Drugs Dermatol. 2010 Jan;9(1):68-70.

Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.

Acta Derm Venereol. 2007;87(1):74-5. doi: 10.2340/00015555-0132.

Recent advances in mucous membrane pemphigoid.

Curr Opin Ophthalmol. 2008 Jul;19(4):292-7. doi: 10.1097/ICU.0b013e328302cc61.

引用本文的文献

Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics.

Front Immunol. 2023 Jan 5;13:1050373. doi: 10.3389/fimmu.2022.1050373. eCollection 2022.

Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits.

J Clin Med. 2019 Aug 15;8(8):1227. doi: 10.3390/jcm8081227.

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.

An Bras Dermatol. 2019 Apr;94(2 Suppl 1):33-47. doi: 10.1590/abd1806-4841.2019940207. Epub 2019 Jun 30.

Ocular Manifestations and Management of Autoimmune Bullous Diseases.

J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):195-210. doi: 10.4103/jovr.jovr_86_18.

Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment.

Ophthalmol Ther. 2019 Mar;8(1):5-17. doi: 10.1007/s40123-019-0164-z. Epub 2019 Jan 29.

The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Eye (Lond). 2017 Feb;31(2):301-332. doi: 10.1038/eye.2016.284. Epub 2017 Jan 20.

The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature.

J Res Med Sci. 2016 Jun 14;21:37. doi: 10.4103/1735-1995.183992. eCollection 2016.

Bullous pemphigoid during ustekinumab therapy.

JAAD Case Rep. 2015 Oct 2;1(6):359-60. doi: 10.1016/j.jdcr.2015.07.014. eCollection 2015 Nov.

Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom.

Eye (Lond). 2011 Sep;25(9):1207-18. doi: 10.1038/eye.2011.175. Epub 2011 Jul 29.

Treatment strategies in mucous membrane pemphigoid.

Ther Clin Risk Manag. 2008 Jun;4(3):617-26. doi: 10.2147/tcrm.s1140.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验